Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Vitrectomy in eyes with diabetic retinopathy and light perception vision: a comprehensive outcome analysis
Author Affiliations & Notes
  • Hamid Hosseini
    Ophthalmology, University of California Los Angeles, Los Angeles, California, United States
    Harbor-UCLA Medical Center, Torrance, California, United States
  • Reza Kianian
    Ophthalmology, University of California Los Angeles, Los Angeles, California, United States
  • Weilin Song
    Ophthalmology, University of California Los Angeles, Los Angeles, California, United States
  • Deyu Sun
    Ophthalmology, University of California Los Angeles, Los Angeles, California, United States
  • judy Figueroa
    Ophthalmology, University of California Los Angeles, Los Angeles, California, United States
  • Jack B. Margines
    Ophthalmology, University of California Los Angeles, Los Angeles, California, United States
  • Jiwei Sheng
    Ophthalmology, University of California Los Angeles, Los Angeles, California, United States
  • Kirk Hou
    Ophthalmology, University of California Los Angeles, Los Angeles, California, United States
  • Pradeep Prasad
    Ophthalmology, University of California Los Angeles, Los Angeles, California, United States
  • Footnotes
    Commercial Relationships   Hamid Hosseini None; Reza Kianian None; Weilin Song None; Deyu Sun None; judy Figueroa None; Jack B. Margines None; Jiwei Sheng None; Kirk Hou None; Pradeep Prasad None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 4017. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hamid Hosseini, Reza Kianian, Weilin Song, Deyu Sun, judy Figueroa, Jack B. Margines, Jiwei Sheng, Kirk Hou, Pradeep Prasad; Vitrectomy in eyes with diabetic retinopathy and light perception vision: a comprehensive outcome analysis. Invest. Ophthalmol. Vis. Sci. 2024;65(7):4017.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate visual and anatomical outcomes and prognostic factors of pars plana vitrectomy (PPV) in eyes with proliferative diabetic retinopathy and light perception vision at UCLA affiliated county hospitals from April 2018 to April 2022.

Methods : In this retrospective chart review study, medical records of patients who underwent pars plana vitrectomy for diabetic retinopathy and their visual acuity was light perception were reviewed. Exclusion criteria was vitrectomy for indications other than diabetic retinopathy and loss of follow up. Preoperative, intraoperative and postoperative characteristics were extracted.

Results : Fifty eyes from 50 patients included. Average age was 51.42 (±9.09) years old, 46% were female.16 eyes had tractional retinal detachment (TRD) and 16 eyes had rhegmatogenous retinal detachment (RRD). Preop characteristics included:
Wait time until surgery: 42 (45.91)
Visual acuity on sign up (logMAR): 2.7
IOP: 17.65 (10.97)
Vitreous hemorrhage (yes, %): 45 (90%)
History of Avastin injectin excluding preop (yes, %): 19 (38%)
Preop Avastin (yes, %): 29 (58%)
Prior PRP (yes, %): 19 (38%)
Mac status (on, %): 34 (68%)
NVG Glaucoma (yes, %): 4 (8%)
Intraoperative characteristics included:
25 Gauge Vitrectomy (Yes, %): 32 (64%)
CEIOL Combined (Yes, %): 10 (20%)
Length of surgery (mean, SD): 2.1 (1.18) hours
Air fluid exchange (yes, %): 39 (78%)
Silicon oil tamponade (yes, %): 13 (26% )
Retinectomy (yes, %): 2 (4%)
PFL use (yes, %): 8 (16%)
Tamponade used (yes, %): 6 (12% C3F8, SF6 6(12%), Air 6(12%)
Postoperative characteristics included:
Post operative month (POM) 1 VA (LogMAR, SD): 1.99 (0.78) {20/2000}; p<0.0001
POM6 VA: 1.70 (0.95) {20/1000}; p<0.0001
Final VA : 1.69 (1.02) {20/1000}
POM1 IOP (mean, SD): 18.02 (9.59)
Final IOP (mean, SD): 16.37 (6.49)
VH post-op (yes, %): 15 (38.5%)
PRP post-op (yes, %): 2 (5.1 %)
Avastin post-op (yes, %): 10 (25.6%)
Mac off post-op (yes, %): 6 (15.4%)
POM 6 4 NLP + 5 LP = 9 (24.3%)

Factors associated with final retinal reattachment are shown in table 1

Conclusions : Vitrectomy significantly improves vision among PDR patients within 6 months. However, 25% of patients did not have visual improvements. Length of surgery and the use of silicone oil which posed the biggest risk factors for worse visual outcome, number of vitrectomies, status of macula pre-operatively, and the diagnoses of PVR and combined TRD/RRD were significant risk factors for retinal reattachment.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×